Avenue Therapeutics, Inc. (ATXI)
OTCMKTS
· Delayed Price · Currency is USD
0.2501
-0.0079 (-3.06%)
Apr 24, 2025, 3:37 PM EDT
Avenue Therapeutics Employees
Avenue Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$5,826,000
Market Cap
787.74K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Northwest Biotherapeutics | 25 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Avenue Therapeutics News
- 5 months ago - Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 7 months ago - Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - GlobeNewsWire
- 8 months ago - Avenue Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 9 months ago - Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 11 months ago - Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds - GlobeNewsWire